AEON Biopharma, Inc. - AEON

All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)? Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).

Files summary

Total files loaded: 14
Latest filed: Apr 03, 2026
Form Count
8-K 7
4 5
SCHEDULE 13D/A 1
SCHEDULE 13D 1

Latest files

Filed Form Report period Accession SEC
Apr 03, 2026 4 Apr 02, 2026 0001104659-26-039697 View
Mar 11, 2026 4 Feb 17, 2026 0001104659-26-026550 View
Mar 09, 2026 8-K Mar 06, 2026 0001837607-26-000009 View
Mar 05, 2026 4 Feb 17, 2026 0001104659-26-024231 View
Mar 05, 2026 4 Feb 17, 2026 0001104659-26-024233 View
Feb 19, 2026 4 Feb 17, 2026 0001104659-26-017726 View
Jan 29, 2026 SCHEDULE 13D/A 0001213900-26-009785 View
Jan 29, 2026 SCHEDULE 13D 0001213900-26-009802 View
Jan 21, 2026 8-K Jan 21, 2026 0001837607-26-000005 View
Jan 12, 2026 8-K Jan 12, 2026 0001837607-26-000002 View
Dec 15, 2025 8-K Dec 15, 2025 0001837607-25-000092 View
Dec 04, 2025 8-K Dec 04, 2025 0001837607-25-000088 View
Nov 14, 2025 8-K Nov 14, 2025 0001837607-25-000084 View
Nov 13, 2025 8-K Nov 12, 2025 0001837607-25-000072 View